<DOC>
	<DOC>NCT02370446</DOC>
	<brief_summary>The purpose of this study is to see if using the MedLog is helpful to patients. Since the investigators do not yet know if this MedLog is helpful, some patients will receive it and some will receive our standard of care. The investigators want to know whether providing patients with this additional information is helpful and if having this additional information about their treatment schedule has an effect on their quality of life.</brief_summary>
	<brief_title>Testing a Personalize Medication Log for Patients With Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<criteria>Diagnosis of lymphoma No prior treatment for lymphoma Scheduled to receive CHOP14 +/ Rituximab, CEOP 21, CHOPE or EPOCH +/ Rituximab Age 18 or older Able to speak and read English Documented major psychopathology or cognitive impairment likely in the judgment of the research staff to interfere with the participation or completion of the protocol.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Medication Log</keyword>
	<keyword>15-008</keyword>
</DOC>